UNLIMITED TURBO LONG - JOHNSON & JOHNSON Share Price

Certificat

J1MMB

NLBNPNL2IY75

Real-time Euronext Paris 04:41:40 27/06/2024 pm IST
2.386 EUR +0.59% Intraday chart for UNLIMITED TURBO LONG - JOHNSON & JOHNSON
Current month-3.93%
1 month-7.05%
Date Price Change
27/24/27 2.386 +0.59%
26/24/26 2.372 -3.97%
25/24/25 2.47 -5.22%
24/24/24 2.606 +2.00%
21/24/21 2.555 +6.41%

Real-time Euronext Paris

Last update June 27, 2024 at 04:41 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer BNP Paribas BNP Paribas
J1MMB
ISINNLBNPNL2IY75
Date issued 03/10/2023
Strike 122.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.235
Lowest since issue 2.145

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
146.8 USD
Average target price
171.7 USD
Spread / Average Target
+16.96%
Consensus
  1. Stock Market
  2. Certificates
  3. J1MMB Certificat